Background and study aims: Low dose photodynamic therapy (LDPDT) may modify the mucosal immune response and may thus provide a therapy for Crohn's disease. We evaluated the efficacy and safety of this technique in a murine T cell-mediated colitis model.
Type
research article
Web of Science ID
WOS:000293393600008
Author(s)
Favre, L.
Borle, F.
Velin, D.
Bachmann, D.
Bouzourene, H.
Ballabeni, P.
Gabrecht, T.
Michetti, P.
Date Issued
2011
Published in
Volume
43
Issue
7
Start page
604
End page
616
Editorial or Peer reviewed
REVIEWED
Written at
EPFL
Available on Infoscience
June 1, 2011
Use this identifier to reference this record